First in Hong Kong to Secure DH Certification and HKHA Registration

Shenzhen Rongjin Technology Achieves Breakthrough with SARS-CoV-2/RSV/ADV/MP & Flu A/B Antigen Rapid Test Kit – First in Hong Kong to Secure DH Certification and HKHA Registration

Shenzhen Rongjin Technology Co., Ltd. has reached a historic milestone with its independently developed SARS-CoV-2/RSV/ADV/MP & Flu A/B Antigen Rapid Test Kit, now officially certified by the Hong Kong Department of Health (DH) and registered under the Hong Kong Hospital Authority (HKHA).

As the first and only brand in Hong Kong to achieve regulatory approval for a six-pathogen respiratory panel, Rongjin Technology has demonstrated exceptional innovation in IVD (In Vitro Diagnostics), with over 10 million test kits distributed globally.

This accomplishment underscores:

✅ Unmatched Technical Expertise – Rigorous R&D and quality control for precise, reliable results.
✅ Global Health Impact – A scalable solution for combating respiratory outbreaks worldwide.
✅ Regulatory Leadership – Recognition by Hong Kong’s top health authorities sets a new industry benchmark.

Rongjin Technology remains committed to advancing accessible, high-performance diagnostic tools to safeguard public health.